123 related articles for article (PubMed ID: 9651805)
21. Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study.
Harrington DS; Ye YL; Weisenburger DD; Armitage JO; Pierson J; Bast M; Purtilo DT
Hum Pathol; 1987 Sep; 18(9):924-8. PubMed ID: 3497862
[TBL] [Abstract][Full Text] [Related]
22. Non-hodgkin's lymphomas in Saskatchewan: a clinicopathologic study.
Cherian T; Skinnider LF; Wright JL; Komjathy G
Can Med Assoc J; 1978 Sep; 119(5):435-41. PubMed ID: 356951
[TBL] [Abstract][Full Text] [Related]
23. [Pathology and pathogenesis of enzootic bovine leukosis. 4. Blood morphology findings in cases of leukosis and preleukosis].
Urbaneck D; Wittmann W
Arch Exp Veterinarmed; 1969; 23(6):1141-61. PubMed ID: 4915157
[No Abstract] [Full Text] [Related]
24. Morphometric characterisation of 52 B cell non-Hodgkin's lymphomas.
van der Valk P; Mosch A; Kurver PJ; Meijer CJ
J Clin Pathol; 1983 Mar; 36(3):289-97. PubMed ID: 6600749
[TBL] [Abstract][Full Text] [Related]
25. A simplified working formulation of non-Hodgkin's lymphomas based on quantifiable histologic criteria.
Schultz HB; Ersbøll J; Nissen NI; Hou-Jensen K
Cancer; 1989 Dec; 64(12):2532-40. PubMed ID: 2819662
[TBL] [Abstract][Full Text] [Related]
26. Comparison of working formulation and REAL classification of non-Hodgkin's lymphoma: an analysis of 52 cases.
Aggarwal D; Gupta R; Singh S; Kudesia M
Hematology; 2011 Jul; 16(4):195-9. PubMed ID: 21756534
[TBL] [Abstract][Full Text] [Related]
27. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms.
Lee SS; Cho KJ; Kim CW; Kang YK
Histopathology; 1999 Oct; 35(4):345-54. PubMed ID: 10564389
[TBL] [Abstract][Full Text] [Related]
29. Central nervous system lymphomas: a histologic and immunophenotypic analysis.
Muzaffar S; Siddiqui MS; Siddiqui I; Soomro IN; Pervez S; Kayani N; Hasan SH
J Pak Med Assoc; 2000 May; 50(5):141-4. PubMed ID: 11242711
[TBL] [Abstract][Full Text] [Related]
30. An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas.
Payne CM; Grogan TM; Cromey DW; Bjore CG; Kerrigan DP
Lab Invest; 1987 Aug; 57(2):200-18. PubMed ID: 3497304
[TBL] [Abstract][Full Text] [Related]
31. Computerized classification of nuclear profiles in non-Hodgkin's lymphomas.
Marchevsky AM; Klapper E; Gil J
Am J Clin Pathol; 1987 May; 87(5):561-8. PubMed ID: 3578131
[TBL] [Abstract][Full Text] [Related]
32. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
34. Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades--should peripheral T-cell lymphoma be considered separately?
Cheng AL; Chen YC; Wang CH; Su IJ; Hsieh HC; Chang JY; Hwang WS; Su WC; Liu TW; Tien HF
J Clin Oncol; 1989 Jun; 7(6):725-31. PubMed ID: 2654330
[TBL] [Abstract][Full Text] [Related]
35. New REAL clinical entities.
Fisher RI; Miller TP; Grogan TM
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity.
Yamanaka N; Harabuchi Y; Kataura A
Cancer; 1992 Nov; 70(9):2342-9. PubMed ID: 1394063
[TBL] [Abstract][Full Text] [Related]
38. Large cell lymphoma. II. Differential diagnosis of centroblastic and B-immunoblastic subtypes by morphometry on cytologic preparations.
Ball PJ; van der Valk P; Kurver PH; Lindeman J; Meijer CJ
Cancer; 1985 Jan; 55(2):486-92. PubMed ID: 3880659
[TBL] [Abstract][Full Text] [Related]
39. Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.
Jones SE; Fuks Z; Bull M; Kadin ME; Dorfman RF; Kaplan HS; Rosenberg SA; Kim H
Cancer; 1973 Apr; 31(4):806-23. PubMed ID: 4574662
[No Abstract] [Full Text] [Related]
40. Non-Hodgkin's lymphoma. A comparison of the working formulation with the Rappaport classification.
Jose CC; Krishnaswami H; Oommen R; Rangad F; Roul RK; Singh AD
Indian J Cancer; 1987 Jun; 24(2):99-106. PubMed ID: 3319895
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]